Thursday, 12 November 2026
Potentially unnecessary knee imaging rises, Automated aged care assessments questioned, Mobi insulin pump recall
- 01
Potentially unnecessary knee imaging rose sharply among older Australians
MBS-funded CT knee scans increased by 83% per head among people aged 45 years and over in the five years to 2023–24, the Australian Commission on Safety and Quality in Health Care found. CT use rose from 261 to 478 scans per 100,000 people, while knee ultrasound increased by 26% and knee replacement surgery by 17% over the periods analysed. The Commission warned that potentially unnecessary imaging for osteoarthritis could lead to needless referrals, further tests and surgery, although MBS items do not record the reason for imaging. RACGP guidance describes imaging's diagnostic role as limited, while the Commission's clinical care standard supports diagnosis through history and examination when no red flags are present. Knee arthroscopy rates fell by around half in the decade to 2023–24, while MBS-subsidised knee MRI increased by 6%.
via RACGP newsGP
- 02
Ombudsman questions fairness of automated aged care assessments
The Commonwealth Ombudsman raised serious concerns about the reliability, transparency and human safeguards of the automated system determining older Australians’ access to home support. Introduced on 1 November 2025, the Integrated Assessment Tool determines eligibility, funding levels and priority categories from information entered by assessors, with its key outcomes unable to be overridden under current law. Although the investigation did not assess the algorithm’s clinical appropriateness, it found design and development deficiencies that raised questions about the reliability of its results and recommended independent clinical review. The Federal Government announced an independent review of aged care classification and prioritisation mechanisms and a new escalated pathway for certain assessment decisions. The Department of Health, Disability and Ageing accepted or accepted in principle the seven recommendations directed to it, but rejected several propositions bearing on public confidence in the system.
via RACGP newsGP
- 03
Tandem recalls 80,900 Mobi pumps after insulin delivery interruptions
Tandem Diabetes Care recalled more than 80,900 Mobi insulin pumps after false occlusion alarms interrupted insulin delivery. The company had received 230 reports of adverse events requiring medical intervention or hospitalisation as of 29 October, with no deaths reported. Increased friction within the pump’s drive module can reduce motor power and trigger a false alarm, suspending insulin delivery until the user acknowledges it and resumes therapy; repeated alarms can increase the risk of high blood glucose. Tandem said customers may continue using the pumps but must respond to occlusion alarms and have a backup insulin delivery method, and instructed users to contact customer support if alarms persist after troubleshooting or repeatedly disrupt therapy.
via MedTech Dive
- 04
Asthma deaths remain high as council urges coordinated care
Asthma claimed 484 Australian lives in 2025, little changed from 481 deaths in 2024. Women accounted for around two-thirds of deaths, while people aged over 75 represented 44% of all deaths and 68% of female deaths. New South Wales recorded the highest state toll, with 168 deaths, followed by Victoria with 121 and Queensland with 85. The National Asthma Council called for GP-led multidisciplinary management involving pharmacists, practice nurses and asthma educators. The updated Australian Asthma Handbook recommends anti-inflammatory reliever therapy, such as budesonide/formoterol, for all adults and adolescents diagnosed with asthma.
via RACGP newsGP
- 05
US faces possible loss of measles elimination status
The US could lose its measles elimination status following a four-day review by a Pan American Health Organization committee. The regional World Health Organization body will determine whether the country has maintained elimination. Measles cases have soared in recent years, and at least eight deaths have been reported this year. The outcome remains pending, although STAT reported that signs pointed to the status being withdrawn.
- 06
Google launches healthcare-specific Gemini platform in limited preview
Google Cloud has launched Gemini for healthcare, an agentic AI platform for clinical and administrative use by healthcare providers and payers. The platform connects with electronic health records, claims workflows and other systems to surface patient records, prepare paperwork and check insurance details. It includes integrations with Epic and Oracle systems, as well as selected third-party tools, and allows organisations to manage AI models from Google, OpenAI and Anthropic under one governance framework. Google said the platform was developed with clinicians and insurers to meet healthcare privacy and security requirements and reduce administrative burden. It is available in preview to selected early adopters, with broader enterprise access planned but no launch date disclosed.
via Healthcare Dive
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.